4processed

Form 4 — Insider Transaction

Avalo Therapeutics, Inc.(AVTX)

Filing Date

May 21, 2026

Accepted

May 21, 2026

Accession No.

0001677896-26-000006

CIK

0001534120

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
VARKI PAULChief Legal OfficerOther24.3K$027.9KCommon StockMay 21, 2026